FDA and HHS Appoint AI Chiefs

May 8, 2025Policy & Regulation, Technology, Health Care, Artificial Intelligence, Policy, Regulatory, Food and Drug Administration (FDA)

In the last two weeks, the Department of Health and Human Services (HHS) has filled key artificial intelligence (AI) positions at HHS and the U.S. Food and Drug Administration (FDA). These appointments, as well as recent statements from HHS and FDA leadership, align with the Trump administration’s intention to use AI to improve regulatory efficiency at HHS and beyond.

Read More

Get the latest FDA and related regulatory developments critical to the life sciences industry delivered to your inbox.

Eye on FDA

A series focused on important FDA and related regulatory developments critical to the life sciences industry.